UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005503
Receipt number R000006524
Scientific Title First-line trial of CBDCA + S-1 + Gefitinib for patients with advanced or reccurent NSCLC patients harboring activating mutation of the EGFR gene -Phase II trial-
Date of disclosure of the study information 2011/05/01
Last modified on 2017/08/13 09:01:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

First-line trial of CBDCA + S-1 + Gefitinib for patients with advanced or reccurent NSCLC patients harboring activating mutation of the EGFR gene
-Phase II trial-

Acronym

Phase II trial of CBDCA + S-1 + Gefitinib

Scientific Title

First-line trial of CBDCA + S-1 + Gefitinib for patients with advanced or reccurent NSCLC patients harboring activating mutation of the EGFR gene
-Phase II trial-

Scientific Title:Acronym

Phase II trial of CBDCA + S-1 + Gefitinib

Region

Japan


Condition

Condition

non small cell lung cancer

Classification by specialty

Pneumology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

to investigate the efficacy of CBDCA + S-1 + Gefitinib for patients with advanced or reccurent NSCLC patients harboring activating mutation of the EGFR gene

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Phase II


Assessment

Primary outcomes

The rate of one year progression free survival (1 year PFS rate)

Key secondary outcomes

response rate
progression free survival (PFS)
overall survival (OS)
safety


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

CBDCA + S1 + Gefitinib

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) diagnosis of NSCLC
2) advanced (stage IIIB who can not treat radiation therapy, and stage IV) or reccurent NSCLC patients
3) the patients who have the target region for RECIST v1.1
4) harboring activating mutation of EGFR gene (exon 19 delation, and L858R)
5) non perior chemotherapy, or 1 year or more after adjuvant chemotherapy
6) 20 years old or more
7) PS 0-1
8) good condition of main organ
9) over 12 weeks of lifetime expectancy
10) agreement of informed concent for this trial

Key exclusion criteria

1) the patients who have interstitial change.
2) allergy of the medication
3) double cancer
4) un-controled pleural effusion and ascites
5) severe conplications, including AMI, un-controled angina pectoris, and un-controled diabetis and hypertension
6) synptomatic brain metastasis
7) radiation therapy which has thoracic field
8) the patients who treat with flucytosine
9) the case of pregnancy and lactation
10) the doctors' jundgement of expurgate

Target sample size

28


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shinji Atagi

Organization

National hospital organization Kinki-Chuo Chest Medical Center

Division name

thoracic oncology

Zip code


Address

1180, nagasone-cho, kita-ku, sakai-city, osaka

TEL

072-252-3021

Email

s-atagi@kch.hosp.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Akihiro Tamiya

Organization

National hospital organization Kinki-Chuo Chest Medical Center

Division name

thoracic oncology

Zip code


Address

1180, nagasone-cho, kita-ku, sakai-city, osaka

TEL

072-252-3021

Homepage URL


Email

atamiya@kch.hosp.go.jp


Sponsor or person

Institute

National hospital organization Kinki-Chuo Chest Medical Center

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

osaka prefectual medical center for respiratory and allergic diseases

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2011 Year 04 Month 19 Day

Date of IRB


Anticipated trial start date

2011 Year 05 Month 01 Day

Last follow-up date

2014 Year 04 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2017 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2011 Year 04 Month 25 Day

Last modified on

2017 Year 08 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006524


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name